http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-409039-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b49b25798cc9813e3f4a0fbe099b95ab
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G79-04
filingDate 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a9bf062045411777cc9e72acbd00275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc904fe53a98bbb015dd654ff2249d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1f1b0ff9c48cc485f72d681159e8d6
publicationDate 2015-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-409039-A1
titleOfInvention Chiral polyampholyte derivatives of dimethylphosphinic acid, polyalkylene polyamines and phenylalanine and the method of their preparation
abstract The invention relates to chiral polyamolytolytes of dimethylphosphinic acid derivatives, polyalkylene polyamines and phenylalanine, which are intended for use as enantioselectors and diastereoselectors, and complexones for the production of chiral homogeneous and heterogeneous catalysts of the general formula I, in which A denotes a fragment of the dimethylphosphinic acid fragment in polyampolite, while B is a fragment of the polyalkylene polyamine structure in which nip can be the same or different and denote integers from 2 to 12, while q is the number of aminopolyalkene structures and is from 2 to 6, y is the number of polyaminopolyalkene fragments in the polymer, while C denotes a fragment of the phenylalanine structure, and az denotes the number of such fragments in the polyampholite, with the free places of fragment A only binding with the free places in fragment B and C. The invention also discloses a method of producing chiral pol of phospholinic acid derivatives, polyalkylene polyamines and phenylalanine derivatives of the general formula I, which consists in the first stage that one molar part of phosphinic acid is reacted with at least one molar part of formaldehyde and at least two molar parts of -NH- groups to which consists of the sum of -NH- groups derived from a polyalkylene polyamine selected from the group consisting of: 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 2-methyl-1 , 5-diaminopentane, 1,2-diaminocyclohexane, bis (hexamethylene) triamine, diethylenetriamine, N- (3-aminopropyl) -1,3-diaminopropane, N- (2-aminoethyl) -1,3-diaminopropane, N, N '-bis (3-aminopropyl) ethylenediamine, triethylenetetramine, tetraethylenepentamine and pentaethylenehexamine, and -NH- groups derived from phenylalanine, and the reaction is carried out at a temperature of 273-373K, in water, in the presence of an activator in the form of any Bronsted acid, until reacting s of losses and the formation of a chiral polyampholite containing structural fragments of dimethylphosphinic acid, polyalkylene polyamine and phenylalanine, which in the third stage is subjected to a crosslinking of at least 0.5 mol part of formaldehyde. The resulting chiral polyampolite is separated from the reaction mixture by decanting, filtration or centrifugation, optionally by evaporation of volatile components under reduced pressure.
priorityDate 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457766247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421005803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415780649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID479307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419964171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408884947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429643640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129808374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485540

Total number of triples: 55.